Literature DB >> 15165701

The influence of sex on limbic volume and perfusion in AD.

David J A Callen1, Sandra E Black, Curtis B Caldwell, Cheryl L Grady.   

Abstract

The goal of the current study was to determine whether Alzheimer's disease (AD) pathology affects the limbic system of men and women differently as measured by in vivo neuroimaging. Magnetic resonance imaging (MRI) and coregistered single photon emission computed tomography (SPECT) were used to examine the limbic system in 20 men and 20 women with probable AD compared to 40 age- and education-matched normal controls (20 men, 20 women). Limbic volumes and relative perfusion values were obtained from the MR images and coregistered SPECT scans, respectively. No significant differences were found between sexes in limbic volumes or relative perfusion values in the normal controls. Many limbic regions were significantly affected in both men and women with AD compared to normal controls. However, only the men with AD displayed atrophy in the orbitofrontal cortex, middle and posterior cingulate cortices, hypothalamus, and mamillary bodies, and relative hypoperfusion in the anterior and middle cingulate cortices. Women with AD exclusively showed anterior thalamic atrophy. Separating men and women did not substantially improve diagnostic classification.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165701     DOI: 10.1016/j.neurobiolaging.2003.08.011

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  8 in total

1.  Sex differences in grey matter atrophy patterns among AD and aMCI patients: results from ADNI.

Authors:  Martha Skup; Hongtu Zhu; Yaping Wang; Kelly S Giovanello; Ja-an Lin; Dinggang Shen; Feng Shi; Wei Gao; Weili Lin; Yong Fan; Heping Zhang
Journal:  Neuroimage       Date:  2011-02-26       Impact factor: 6.556

2.  Sex-Related Reserve Hypothesis in Alzheimer's Disease: Changes in Cortical Thickness with a Five-Year Longitudinal Follow-Up.

Authors:  Juyoun Lee; Hanna Cho; Seun Jeon; Hee Jin Kim; Yeo Jin Kim; Jeongmin Lee; Sung Tae Kim; Jong-Min Lee; Juhee Chin; Samuel N Lockhart; Ae Young Lee; Duk L Na; Sang Won Seo
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.

Authors:  M V Spampinato; B R Langdon; K E Patrick; R O Parker; H Collins; E Pravata'
Journal:  Neuroradiology       Date:  2016-09-02       Impact factor: 2.804

Review 4.  The genetics of sex differences in brain and behavior.

Authors:  Tuck C Ngun; Negar Ghahramani; Francisco J Sánchez; Sven Bocklandt; Eric Vilain
Journal:  Front Neuroendocrinol       Date:  2010-10-15       Impact factor: 8.606

Review 5.  Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology.

Authors:  Makoto Ishii; Costantino Iadecola
Journal:  Cell Metab       Date:  2015-09-10       Impact factor: 27.287

6.  Quantitative magnetic susceptibility assessed by 7T magnetic resonance imaging in Alzheimer's disease caused by streptozotocin administration.

Authors:  Sangwoo Kim; Youngjeon Lee; Chang-Yeop Jeon; Keunil Kim; Youngjae Jeon; Yeung Bae Jin; Sukhoon Oh; Chulhyun Lee
Journal:  Quant Imaging Med Surg       Date:  2020-03

7.  In vivo mapping of incremental cortical atrophy from incipient to overt Alzheimer's disease.

Authors:  Giovanni B Frisoni; Annapaola Prestia; Paul E Rasser; Matteo Bonetti; Paul M Thompson
Journal:  J Neurol       Date:  2009-02-28       Impact factor: 4.849

8.  Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer's disease.

Authors:  Lisa S Robison; Olivia J Gannon; Melissa A Thomas; Abigail E Salinero; Charly Abi-Ghanem; Yannick Poitelon; Sophie Belin; Kristen L Zuloaga
Journal:  J Neuroinflammation       Date:  2020-09-29       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.